Hatem Mahmoud S. Alahwal 

Date of Birth: 26^th may 1985

Citizenship: Saudi Arabia 

halahwal@kau.edu.sa

Degrees:

-Completed a subspecialty fellowship in Multiple Myeloma at the University of British Columbia / Vancouver general hospital under the supervision of Dr. Kevin Song (June 2019).

-Fellow of the Royal College of Physicians of Canada (FRCPC) in Hematology (November 2018).

-Fellow of the Royal College of Physicians of Canada (FRCPC) in Internal Medicine (May 2017).

-Master’s degree in Public health (MPH) (Quantitative methods) at Harvard school of public health (Aug-2012 to May-2013) (GPA 3.675/4.0).

-Bachelor of Medicine, Bachelor of Surgery (MBBS), (V. Good (GPA 4.19/5.0) with 2^nd degree of Honor) King Abdulaziz University-school of Medicine, (September 2002-April 2009).

Employment and Professional experience:

-  Clinical hematology Consultant/Assistant professor at King Abdul-Aziz University Hospital. (Aug-09 - Current).

-   Vice president of the Saudi society of hematology, (Oct 2020 – Current).

-   Assistant program director, Hematology fellowship program at King Abdulaziz University. (May 2021 – Current)

- Multiple Myeloma fellowship at the BMT program of British Columbia (July 2018 – June 2019).

- Hematology Residency program at the University of British Columbia (July 2016 – June 2018).

- Internal medicine residency program at the University of British Columbia (Started July 2013-June 2016).

- Masters of public health program (Aug-2012 to May-2013) Harvard school of Public Health. 

Medical Licensing:

- Educational license from the college of physicians and surgeons of British Columbia (July 2013- June 2019) CPSID: 34429 (British Columbia).

- Registered consultant and licensed to practice by the Saudi commission for health specialties (June 2019 – Current), Profile number: 12RM0060064.

Awards:

- Best presentation at the 2018 UBC Hematology research day.

- Nominated for the Richard E Beck Award for outstanding teaching by a fellow 2019.

- 2^nd degree of honor during graduation from medical school (2008).

- Awarded degree of excellence for academic performance during medical school (2003).

- Degree of Excellence for Active participation and performance in The King Abdul-Aziz & his Companions Foundation for the gifted program (2001).

Research and academic activities:

-   Mortality from Multiple Myeloma Within One Year Following Autologous Stem Cell Transplantation: Defining an Ultra-high Risk Population. Clin Lymphoma Myeloma Leuk. 2021 Jul;21(7):476-482. doi: 10.1016/j.clml.2021.02.012.

-   Web-based expert system with quick response code for beta-thalassemia management. Health Informatics J. Jan-Mar 2021;27(1):1460458221989397. doi: 10.1177/1460458221989397.

-   Maintenance therapy with either Lenalidomide or Bortezomib equally improves PFS and OS in High Risk Myeloma initially treated with Auto transplant. (Plenary session oral presentation at the International myeloma workshop (Sep 2019).

-    Characteristics of Patients (pts) Who Relapse and Die of Multiple Myeloma (MM) within One Year Post Frontline Autologous Stem Cell Transplant (ASCT) in the Novel Agent Era: An Ultra-High Risk Population. (Abstract poster presentation ASH 2018 - Blood 2018 132:3440; doi: https://doi.org/10.1182/blood-2018-99-111533).

-   Does Bendamustine adversely affect stem cell mobilization? A review of mantle cell lymphoma patients in the BR vs CHOPR eras. (Abstract poster presentation ASH 2018 - Blood 2018 132:4556; doi: https://doi.org/10.1182/blood-2018-99-114371).

-  Bortezomib-Containing Regimens for the Treatment of Newly Diagnosed AL Amyloidosis: Experience of Two Centers in Canada (Abstract poster presentation at ASH 2016. Blood 2016 128:2131).

-   "Outcome in Primary AL Amyloidosis, A retrospective analysis" presented at the internal medicine resident research day at UBC (May 20 2015).

-    Perception of Medical Students during the Foundation Year at King Abdulaziz University. Journal of King Abdulaziz University - Medical Sciences, 19(4), 73-84. (Co-author 2012).

-    Career Counseling Activities and Choice of Specialties among Medical Interns. (Main author, Published at: Bahrain Medical Bulletin, Vol. 32, No. 4, December 2010).

-    Participated in "The effect of community behavior in the prevalence of Dengue fever in our community" done by the department of community and family medicine at K.A.U. (2005)

• Member of the accreditation committee, supervising the role of Students in the Accreditation of The Medical Education Program at King Abdulaziz University, analyzing, writing and producing the undergraduate student report    (2009 - 2010).

• Senior Triage Mentorship, Department of internal medicine, UBC (2015).

   

  Presentations:

• Multiple Myeloma public awareness presentation, Nov 12^th 2020.

• Should we be conducting our own trials to gain approval of SFDA agency? Saudi Hematology Research Group (SHRG) Annual Meeting which will be held on 07 February 2020.

• Maintenance therapy with either Lenalidomide or Bortezomib equally improves PFS and OS in High Risk Myeloma initially treated with Auto transplant. (Plenary session oral presentation at the International myeloma workshop (Sep 2019).

• Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide.

• Myeloproliferative neoplasms.

• Aquired hemophilia.

• Cardiac AL amyloidosis.

• Challenging cases with thrombocytopenia.

• Crizanlizumab for the prevention of pain crises in Sickle Cell Disease.